User:Kofod/sandbox

I would like to suggest two corrections in the section about Insulin_analogue on the Insulin_analogue page.

The article currently states that insulin degludec is being developed. It is already approved and marketed in Europe and other countries, so I suggest to delete 'being' in that sentence.

The article also states that insulin degludec may be injected thrice per week instead of once per day. It is currently approved for once per day, and the reference to the suggestion, that it may be injected thrice per week, is an old article from October 2010. So I suggest to delete the first part about thrice per week to keep it aligned with the description approved by The European Medicines Agency.

The EMA page about insulin degludec as external 3rd party source for both corrections.

Will anyone be able to review this and make the appropriate corrections?


 * Kofod (talk) Kasper Kofod 09:32, 26 September 2014 (UTC)